// App-Quantinova.ai

1125 : Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma

Researchers

Presenter

  • Larry W. Kwak

Principal Investigators

  • Seok-Goo Cho

  • Hideyuki Nakazawa

  • Junji Suzumiya

  • Gayane Tumyan

  • Jin Seok Kim

  • Tobias F Menne

  • Jose Mario Mariz

  • Nikolai Ilyin

  • Wojciech Jurczak

  • Aurelio Lopez Martnez

  • Olga Samoilova

  • Edvard Zhavrid

  • Eduardo Yanez Ruiz

  • Marek Trneny

  • Leslie L. Popplewell

  • Michinori Ogura

  • Won Seog Kim

  • Sang Joon Lee

  • Sung Hyun Kim

  • Keum Young Ahn

  • Christian Buske

Medical Centers

  • Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA

  • Hematology Department, Hospital Germans Trias i Pujol / ICO-IJC, Pamplona, Spain

  • Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Marys Hospital, The Catholic University of Korea College of Medicine,

  • Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Marys Hospital, The Catholic University of Korea College of Medicine,

  • Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan

  • Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan

  • N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

  • Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of.

  • Northern Institute for Cancer Research Newcastle University, Newcastle, United Kingdom

  • Department of Onco-Hematology, Portuguese Institute of Oncology, Porto, Portugal

  • Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

  • Department of Medical Oncology, Hospital Arnau de Vilanova, Lleida, Spain

  • Department of Hematology, Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, Russian Federation

  • N.N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Minsk, Belarus

  • Universidad de La Frontera, Temuco, Chile.

  • Dept. of Hematology, Charles University General Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

  • City of Hope National Medical Center, Duarte, CA

  • Department of Hematology and Oncology, Kasugai Municipal Hospital, Konan, Japan

  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea

  • Celltrion, Inc., Incheon, Korea, Republic Of

  • Clinical Planning Department, CELLTRION, Inc., Incheon, Korea, Republic of (South)

  • Comprehensive Cancer Center Ulm,Ulm,Allemagne

Locations

  • United States

  • Spain

  • Republic of South Korea

  • Japan

  • Russia

  • United Kingdom

  • Portugal

  • Poland

  • Belarus

  • Chile

  • Czech Republic

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • B-lymphocyte antigen CD20

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Rituximab

  • CT-P10

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

  • Parallel Group

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved